Skip to content
Popular Searches
  • # Cancer
  • # FDA
  • # Alzheimer's
  • # FDA Approval
  • # Hoffmann-La Roche
  • # Johnson&Johnson
  • linkedin
  • facebook
  • instagram
  • twitter
  • youtube
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

Living Bioelectronics; A new technology that can detect and heal skin

1 June 2024

Princeton University, New Jersey – Postdoctoral Positions | September 2023

22 September 2023

Understanding P-Value Tables | Z-Table, T-Table, Chi-square Table, and F-Table

3 June 2024

First person who received the genetically modified pig kidney died after two months

12 May 2024

Pembrolizumab, an immunotherapy medication, improves outcomes for patients with soft tissue sarcoma

14 November 2024

Researchers discovered a suite of genes that influence the human head shape

18 November 2023

U.S. FDA Approved Sanofi’s Qfitlia to Treat Hemophilia

30 March 2025

Johnson & Johnson’s DARZALEX FASPRO® Regimen Shows 95% 4-Year Progression-Free Survival in Newly Diagnosed Myeloma Patients

3 June 2025

Dupixent (Dupilumab), Sanofi’s New Targeted Therapy For Chronic Spontaneous Urticaria Approved by the U.S. FDA

19 April 2025

Early Embryo Development Is Influenced by Ancient Viral DNA

20 January 2025

SARS-CoV-2 which causes COVID-19 is widespread in wild animals

31 July 2024

Cancer can be blocked by Statin therapy, which can block the inflammatory protein

5 June 2024

Pleural mesothelioma

Pleural mesothelioma (PM): New therapeutic approach to chemo-and radiotherapy sensitivity enhancement by Medical University of Vienna
Molecular Biology News

Pleural mesothelioma (PM): New therapeutic approach to chemo-and radiotherapy sensitivity enhancement by Medical University of Vienna

Editor's Desk 12 October 2023

A recent research study led by Karin Schelch and Michael Grusch from MedUni Vienna identified the oncoprotein YB-1 as an attractive therapeutic target in PM and demonstrates that indirect targeting of YB-1 is a promising approach to enhance sensitivity to chemo- and radiotherapy. 

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • Cytiva Hiring a Quality Control Technician in Cardiff, United Kingdom
  • PhD Position in Dialysis Therapy – University of Twente, Netherlands
  • Eli Lilly and Company Hiring a Analytical Technical Steward-Peptides in Hyderabad, India – June, 2025
  • ICON Hiring a Clinical Data Programming Lead in Chennai, India
  • PhD Position in Food Biotechnology – University of Reading, United Kingdom
SciRealityPress BiotechReality

A SciRealityPress Associate

DMCA.com Protection Status

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy